The Brain and Mind Experts

What if dementia isn't simply a disease of aging brain cells — but a failure of the brain's support systems over time? In this episode of The Brain and Mind Experts , host Tom Dent sits down with neurologist Dr. Steven Allder to explore groundbreaking discoveries changing how we think about dementia, Alzheimer's disease, sleep, brain injury, and long-term cognitive health. Dr. Allder explains the...

CTE (chronic traumatic encephalopathy) is a progressive brain disease linked to repeated head impacts—often from subconcussions, not just "big" concussions. In this episode of Brain & Mind Experts, Tom Dent sits down with Dr. Emma McWeeny (CEO & Medical Director, Recognition Health) to unpack what's really happening in the brain, why symptoms often appear after damage is underway, and what science...

Dr. Emer MacSweeney and Tom Dent talk about the tests that can diagnose Alzheimer's. For the first time, the U.S. Food and Drug Administration (FDA) has approved a blood test that can help identify Alzheimer's disease in clinical practice. For a disease that is a global pandemic, this kind of accessible testing is critical.  

Retired British professional footballer Ray Clarke , diagnosed with early-onset Alzheimer's, is participating in a clinical trial to slow or stop the progression of the disease. Drawing on a history of head injuries, Ray joins Dr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, and Tom Dent, Executive Chairman of Re:Cognition Health, to urge former contact sport athletes to seek...

The Brain and Mind Experts podcast is your gateway to the latest breakthroughs in cognitive health. Hosted by Dr. Emer MacSweeney and Tom Dent of Re:Cognition Health, each episode explores the causes, treatments, and emerging solutions for memory loss and neurological disorders like Alzheimer's. Join us as we bring hope and expert insight to those navigating the complexities of brain health.

Dr. Emer MacSweeney and co-founder Tom Dent dive deep into why early diagnosis matters more than ever and how new breakthroughs in biomarkers and treatments are transforming the outlook for millions.

Dr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, and Tom Dent, Executive Chairman of Re:Cognition Health, discuss major advancements in treating cognitive disorders, including two new breakthough medications for Alzheimer's. With the first of these revolutionary treatments now available on the market, Re:Cognition Health continues to lead, delivering these medications safely t...